Jeremy Wohlwend
CTO, Boltz
Jeremy is a recent PhD graduate from MIT, advised by Regina Barzilay. Jeremy's research focuses on biomolecuar modeling and applications in immunology. Jeremy is one of the authors of Boltz-1 and Boltz-2, leading open-source models for structure and binding affinity prediction.
Events Jeremy Wohlwend has spoken at
- Drug Discovery Chemistry Europe 2026 11 November 2026 – 12 November 2026